A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence

Conclusions: The study demonstrated dose equivalence and comparable clinical outcomes between the buprenorphine–naloxone film and tablet preparations, whilst showing improved dispensing times and patient ratings of satisfaction with the film. (Source: Drug and Alcohol Dependence)